Generic name |
tocilizumab |
---|---|
Strength |
80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL, 162 mg/0.9 mL |
Form |
intravenous infusion vial, pre-filled syringe |
Special Authority criteria |
Approval period |
---|---|
For the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients 2 years and older who, due to intolerance or lack of efficacy, have not adequately responded to
AND
|
1 year |